Who makes C. jejuni CG8421 Challenge strain?

C. jejuni CG8421 Challenge strain is developed by Johns Hopkins Bloomberg School of Public Health.

What development phase is C. jejuni CG8421 Challenge strain in?

C. jejuni CG8421 Challenge strain is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Johns Hopkins Bloomberg School of Public Health · Phase 1 active Biologic

Generic name	C. jejuni CG8421 Challenge strain
Sponsor	Johns Hopkins Bloomberg School of Public Health
Modality	Biologic
Phase	Phase 1

No approved indications tracked.

No common side effects on file.